An abundance of CD8+ T cells in the tumor microenvironment correlates with improved survival [66], while PD-L1 expression in tumor and other cells in the tumor microenvironment correlates with poor survival rates in breast cancer patients [67]. Here, CD274 is linked to breast carcinoma.